284 related articles for article (PubMed ID: 7996484)
21. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.
Husbands SM; Izenwasser S; Loeloff RJ; Katz JL; Bowen WD; Vilner BJ; Newman AH
J Med Chem; 1997 Dec; 40(26):4340-46. PubMed ID: 9435903
[TBL] [Abstract][Full Text] [Related]
22. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
[TBL] [Abstract][Full Text] [Related]
23. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
25. Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT.
Kaufman MJ; Spealman RD; Madras BK
Synapse; 1991 Nov; 9(3):177-87. PubMed ID: 1776130
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
27. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
Staley JK; Boja JW; Carroll FI; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Mash DC
Synapse; 1995 Dec; 21(4):364-72. PubMed ID: 8869167
[TBL] [Abstract][Full Text] [Related]
28. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
Li LB; Cui XN; Reith MA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
[TBL] [Abstract][Full Text] [Related]
29. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
Cline EJ; Scheffel U; Boja JW; Carroll FI; Katz JL; Kuhar MJ
J Pharmacol Exp Ther; 1992 Mar; 260(3):1174-9. PubMed ID: 1545384
[TBL] [Abstract][Full Text] [Related]
30. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
31. Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.
Little KY; Carroll FI; Cassin BJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1473-83. PubMed ID: 7562524
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter.
Dutta AK; Reith ME; Madras BK
Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505
[TBL] [Abstract][Full Text] [Related]
33. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
34. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
Valchar M; Hanbauer I
J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
[TBL] [Abstract][Full Text] [Related]
35. Central and peripheral cocaine receptors.
Calligaro DO; Eldefrawi ME
J Pharmacol Exp Ther; 1987 Oct; 243(1):61-8. PubMed ID: 2822906
[TBL] [Abstract][Full Text] [Related]
36. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
Madras BK; Fahey MA; Bergman J; Canfield DR; Spealman RD
J Pharmacol Exp Ther; 1989 Oct; 251(1):131-41. PubMed ID: 2529364
[TBL] [Abstract][Full Text] [Related]
37. Radiation inactivation studies of the dopamine reuptake transporter protein.
Berger SP; Farrell K; Conant D; Kempner ES; Paul SM
Mol Pharmacol; 1994 Oct; 46(4):726-31. PubMed ID: 7969052
[TBL] [Abstract][Full Text] [Related]
38. Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.
Boja JW; Cadet JL; Kopajtic TA; Lever J; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Carroll FI
Mol Pharmacol; 1995 Apr; 47(4):779-86. PubMed ID: 7723739
[TBL] [Abstract][Full Text] [Related]
39. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter.
Rudnick G; Wall SC
Mol Pharmacol; 1991 Sep; 40(3):421-6. PubMed ID: 1896028
[TBL] [Abstract][Full Text] [Related]
40. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.
Reith ME; Xu C; Coffey LL
Biochem Pharmacol; 1996 Nov; 52(9):1435-46. PubMed ID: 8937455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
